UMC
0256 S0.300 ↓
0.300 ↓
-0.015 (-4.8%)| High | 0.310 |
| Low | 0.300 |
| Open | 0.310 |
| Volume | 819,700 |
| Volume (B/S) | 173,600 / 36,500 |
| Price Bid/Ask | 0.295 / 0.300 |
| 52w | 0.305 - 0.590 |
| ROE | 9.86 |
| P/E | 13.90 |
| EPS | 2.16 |
| DPS | 0.30 |
| DY | 1.00% |
| NTA | 0.2190 |
| P/B | 1.37 |
| RPS | 13.28 |
| PSR | 2.26 |
| Market Cap | 112.2M |
| Shares (mil) | 373.91 |
| RConQ |
| CAGR |
3Y
63.7%
TTM
27.9%
5Y
17.1%
TTM
-8.8%
|
|
| RSI(14) | Neutral 32.6 |
| Stochastic(14) | Oversold 0.0 |
| Stochastic RSI(14) | Oversold 10.1 |
| Average Volume (3M) | 122,600 |
| Relative Volume | 1.4 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jul, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 Jan 2026 | 31 Jul 2026 | First Interim Dividend | 29 Jan 2026 | 10 Feb 2026 | 0.0030 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
Healthcare sector rerating likely on big-ticket IPOs
The initial public offering (IPO)-led rerating of the local healthcare sector could extend beyond hospitals in 2026, with the potential listings of several mega-healthcare groups in 2026, says Hong Leong Investment Bank (HLIB) Research.TheStar -
LAC Med to make Main Market debut with EaaS push, Indonesia expansion
LAC Med Bhd (KL:LACMED), en route to list on the Main Market of Bursa Malaysia on Dec 10, is positioning itself not as another medical equipment distributor but as a specialist in high-value, highly specialised machines — a space dominated globally by only a handful of manufacturers. Th...TheEdge -
Bright prospects for UMediC Group on new products
UMediC Group Bhd's outlook in the near term is expected to be impacted, among others, by the ringgit's strength against the US dollar.TheStar -
【行家论股】UMediC集团 制造与分销冲击盈利
UMediC集团（UMC，0256，创业板）2026财年首季（截至10月底）净赚178万令吉，同比减少3.58%。...Nanyang -
Analysts split on UMediC's outlook after weaker 1Q earnings
Analysts are split on prospects for UMediC Group Bhd (KL:UMC) after the medical device distributor and manufacturer kicks off its financial year ending July 31, 2026 (FY2026) with weaker first-quarter results.TheEdge
